Phase II study of single agent oral vinorelbine as a first line treatment for postmenopausal patients with locally recurrent or metastatic breast cancer previously treated with anthracycline or taxanes

被引：0
|
作者：
Elebrashi, M. [1 ]
机构：
[1] Mansoura Univ, Clin Oncol, Dakahlia, Egypt
来源：
EUROPEAN JOURNAL OF CANCER | 2016年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
391
引用
收藏
页码：S113 / S113
页数：1
相关论文
共 50 条
  • [21] Phase II study with the combination of capecitabine (C) and vinorelbine (V) in metastatic breast cancer (MBC) previously treated with anthracyclines and taxanes.
    Estevez, LG
    Batista, N
    Sánchez-Rovira, P
    Velasco, A
    Domine, M
    Lobo, F
    Oramas, J
    Cruz, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 63S - 63S
  • [22] Biweekly vinorelbine and tegafur/uracil in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: GEICAM 2000-02 phase II study
    Anton, Antonio
    Barnadas, Agusti
    Florian, Jesus
    Ribelles, Nuria
    Lomas, Maria
    Lao, Juan
    Gonzalez-Quintas, Ana
    Margeli, Mireia
    Paules, Ana Belen
    Gayo, Javier
    Ramos, Manuel
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2011, 13 (04): : 281 - 286
  • [23] A phase I/II study of bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines
    Schmid, P.
    Kuehnhardt, D.
    Kiewe, P.
    Lehenbauer-Dehm, S.
    Schippinger, W.
    Greil, R.
    Lange, W.
    Preiss, J.
    Niederle, N.
    Brossart, P.
    Freier, W.
    Kuemmel, S.
    de Velde, H. Van
    Regierer, A.
    Possinger, K.
    ANNALS OF ONCOLOGY, 2008, 19 (05) : 871 - 876
  • [24] A phase II study of capecitabine and vinorelbine in patients with metastatic breast cancer pretreated with anthracyclines and taxanes
    Estevez, Laura G.
    Batista, Norberto
    Sanchez-Rovira, Pedro
    Velasco, Amalia
    Provencio, Mariano
    Leon, Ana
    Domine, Manuel
    Cruz, Josefina
    Rodriguez, Milva
    CLINICAL BREAST CANCER, 2008, 8 (02) : 149 - 154
  • [25] Phase II study of navelbine plus carboplatin followed by oral navelbine in patients with metastatic/recurrent triple negative breast cancer previously treated with anthracycline and taxane
    El-Sadda, W.
    Halim, I. Abdel
    El-Ibrashi, M.
    CANCER RESEARCH, 2017, 77
  • [26] UFT plus Oral Folinic Acid with Alternating Oral and Intravenous Vinorelbine in Patients with Metastatic Breast Cancer Previously Treated with Anthracyclines and Taxanes
    Coskun, Ugur
    Kaya, Ali Osman
    Alkis, Necati
    Buyukberber, Sueleyman
    Alici, Sueleyman
    Celenkoglu, Goekhan
    Uncu, Dogan
    Ozkan, Metin
    Sevinc, Alper
    Benekli, Mustafa
    ONKOLOGIE, 2009, 32 (10): : 562 - 566
  • [27] Phase II study of ifosfamide plus vinorelbine in metastatic breast cancer patients previously treated with combination chemotherapy
    F. Lobo
    A. Frau
    A. Barnadas
    M. Méndez
    J. Lizón
    M. Provencio
    J. J. Albistur
    P. Martínez
    M. J. Sánchez
    M. Constenla
    L. G. Estévez
    Cancer Chemotherapy and Pharmacology, 1999, 44 : S5 - S8
  • [28] Ramucirumab With Eribulin Versus Eribulin in Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane Therapy: A Multicenter, Randomized, Phase II Study
    Yardley, Denise A.
    Reeves, James
    Dees, E. Claire
    Osborne, Cynthia
    Pau, Devchand
    Ademuyiwa, Foluso
    Soliman, Hatem
    Guthrie, Troy
    Andersen, Jay
    Krekow, Lea
    Choksi, Janak
    Daniel, Brooke
    Danso, Michael
    Favret, Anne
    Oommen, Sanjay
    Brufsky, Adam
    Bromund, Jane L.
    Lin, Yong
    Ibrahim, Ayman B.
    Richards, Paul D.
    CLINICAL BREAST CANCER, 2016, 16 (06) : 471 - 479
  • [29] Phase II study of ifosfamide plus vinorelbine in metastatic breast cancer patients previously treated with combination chemotherapy
    Lobo, F
    Frau, A
    Barnadas, A
    Méndez, M
    Lizón, J
    Provencio, M
    Albistur, JJ
    Martínez, P
    Sánchez, MJ
    Constenla, M
    Estévez, LG
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 44 (Suppl 1) : S5 - S8
  • [30] Pegylated Liposomal Doxorubicin (Caelyx®) and Oral Vinorelbine in First-Line Metastatic Breast Cancer Patients Previously Treated with Anthracyclines
    Livi, L.
    Meattini, I.
    Scotti, V.
    Cardillo, C. De Luca
    Galardi, A.
    Iermano, C.
    Sanchez, L.
    Nori, J.
    Mangoni, M.
    Franzese, C.
    Orzalesi, L.
    Bertocci, S.
    Agresti, B.
    Masoni, T.
    Bianchi, S.
    Cataliotti, L.
    Biti, G.
    JOURNAL OF CHEMOTHERAPY, 2011, 23 (03) : 158 - 162
12345